bioMérieux

Equities

BIM

FR0013280286

Real-time Euronext Paris Other stock markets 09:29:17 11/07/2025 BST			5-day change	1st Jan Change
120.00 ^EUR	-1.32%		+0.84%	+15.94%

06-16	BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	CI
06-16	BioMérieux: agreement to acquire Day Zero Diagnostic	CF

BioMérieux S.A., H1 2020 Earnings Call, Sep 02, 2020

Published on 02/09/2020 at 13:30

Presentation Operator Message
Operator (Operator)

Good day, and welcome to the bioMérieux Half Year 2020 Financial Results Call. Today's conference is being recorded. [Operator Instructions]

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about bioMérieux

BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	06-16	CI
BioMérieux: agreement to acquire Day Zero Diagnostic	06-16	CF
Biomerieux Acquires Day Zero Diagnostics Solutions And Technologies	06-16	RE
BioMérieux S.A. Launches Equine Infectious Respiratory Disease Testing with VETFIRE	06-03	CI
BioMérieux: launches a test for respiratory diseases	06-03	CF
GXO Logistics, Inc. Extends Long-Term Contract Renewal and Extension with BioMerieux	05-22	CI
RBC Capital Downgrades bioMérieux to Sector Perform, Trims PT	05-07	MT
BIOMÉRIEUX : RBC downgrades stock	05-07	CF
BioMérieux: stock falls after RBC's downgrade	05-07	CF
The stock market returns to "Risk On"	04-25
BIOMERIEUX : Remains an attractive investment and top choice in the testing sector	04-24
BIOMÉRIEUX : Invest Securities remains positive, cuts TP	04-22	CF
BioMérieux: launches test for wastewater	04-22	CF
European shares clock marginal losses after ECB eases rates as expected	04-17	RE
BIOMERIEUX : Despite a better-than-expected Q1, investors expressed disappointment with tariffs	04-17
BioMerieux Shares Fall After Warning on Currency-Exchange Hit	04-17	DJ
European shares clock marginal losses after ECB eases rates as expected	04-17	RE
BioMérieux: quarterly revenue up over 13%	04-17	CF
Biomerieux Q1 Total Sales EUR 1.10 Billion	04-17	RE
TP ICAP Midcap Downgrades bioMérieux to Hold, Lowers PT	04-07	MT
BioMérieux's Lumed Apss Software System Wins CE Marking	04-07	MT
Biomerieux Obtains CE-Marking For LUMED APSS	04-07	RE
AlphaValue/Baader Europe Downgrades bioMérieux to Reduce, Trims PT	04-03	MT
BioMerieux Receives FDA 510(k) Clearance for its VITEK®? COMPACT PRO, a New ID/AST System to Fight Against Antimicrobial Resistance	03-18	CI
BioMérieux Gets US FDA Clearance for Microbial Identification Testing System	03-18	MT